Delivery Order SPE2DB20D1100-SPE2DB25FE0TD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,639.08 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order has a completion date of September 2, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Ondansetron is an anti-nausea medication commonly used in military and federal healthcare settings to...
- The Defense Logistics Agency awarded a delivery order valued at $1,238.80 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used to prevent nausea...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,907.29 for Ondansetron ODT 4 mg tablets (30-count packaging) on September 24, 2025, with completion targeted for September 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an anti-nausea medication commonly used in military and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count units) under a firm fixed-price contract valued at $26,561.64. The award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location....
- The Defense Logistics Agency (DLA) awarded a $3,099.83 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets in quantities of 30 units, with an ultimate completion date of July 31, 2025. This non-set-aside contract was competitively awarded on July 30, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is an anti-nausea medication commonly used in military and federal healthcare settings to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,812.82 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packages). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and carries an ultimate completion date of July 22, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,770.55 for Ondansetron ODT 8 mg tablets (30-count packages) on September 10, 2025, with a completion date of September 11, 2025. This firm fixed price contract represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is a widely used anti-nausea medication commonly stocked in military and federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $5,137.00 under a firm fixed-price contract. This non-set-aside award was made on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Ondansetron is a widely used antiemetic medication commonly prescribed to prevent nausea and...
- The Defense Logistics Agency awarded a delivery order valued at $8,691.62 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an anti-nausea medication commonly used in military and federal...
- The Defense Logistics Agency awarded a $10,330.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This contract represents a non-competitive set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0TDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count) valued at $2,863.37. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 23, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a commonly used anti-nausea medication utilized across military healthcare systems to manage post-operative and chemotherapy-related nausea in service members and beneficiaries. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. As a leading pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a comprehensive portfolio of medications and medical supplies to support military and veteran healthcare systems globally. The company's contract awards reflect its capability to compete effectively in federal procurement and fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains for defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/22/25 |